Andy Bailey, Ph.D.
ViruSure
CEO
Biosafety Testing Services
Andy Bailey is a protein chemist and experienced virologist and served for 9 years at the MRC Virology Unit in Glasgow. In 1995, he moved to the industry sector, initially as Director of Virus Validation services with Q-One Biotech Ltd, as manager at the Global Pathogen Safety group of Baxter Healthcare in Vienna, Austria and for the last 17 years as CEO of ViruSure, now a part of the Asahi Kasei Medical group. Over the last 27 years Andy has been actively involved in the virus and prion safety field, presenting at numerous regulatory agencies either in support of products or as an invited speaker at expert workshops.
Biosafety Testing Services
Andy Bailey is a protein chemist and experienced virologist and served for 9 years at the MRC Virology Unit in Glasgow. In 1995, he moved to the industry sector, initially as Director of Virus Validation services with Q-One Biotech Ltd, as manager at the Global Pathogen Safety group of Baxter Healthcare in Vienna, Austria and for the last 17 years as CEO of ViruSure, now a part of the Asahi Kasei Medical group. Over the last 27 years Andy has been actively involved in the virus and prion safety field, presenting at numerous regulatory agencies either in support of products or as an invited speaker at expert workshops.